Prosecution Insights
Last updated: October 27, 2026

Nathan Andrew Bowers, USPTO Patent Examiner

Listed by the USPTO as BOWERS, NATHAN ANDREW

Tech Center 1700 • Art Units: 1651 1656 1731 1759 1775 1796 1797 1798 1799

This examiner grants 60% of resolved cases

Analysis

BOWERS, NATHAN ANDREW is assigned to tech center 1700 and art unit 1651. The profile contains 1381 resolved cases, with a 59.5% allowance rate and a median of 1291 days to allowance. The 31.7% interview lift indicates a substantial association between interviews and improved allowance outcomes in the measured portfolio.

The leading companies are Thermo Fisher Scientific, Global Life Sciences Solutions USA LLC, and Hoffmann-La Roche Inc. The recurring firms are CYTIVA - Grogan, Tuccillo & Vanderleeden, LLP, Muncy, Geissler, Olds & Lowe, P.C., and OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. Practitioners can prioritize interviews while planning for an allowance process centered on 1291 days.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

59.5%
Allow Rate
-5.5% vs TC avg
1,453
Total Applications
+31.7%
Interview Lift
1291
Avg Prosecution Days
Based on 1381 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
13.6%
§102 Novelty
53.8%
§103 Obviousness
18.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17810426 SINGLE-USE CELL CULTURE CONTAINER WITH ONE OR MORE IN-SITU ONLINE SENSORS Final Rejection Hoffmann-La Roche Inc.
18665676 CELL CULTURE SYSTEM AND CELL CULTURE METHOD Non-Final OA CANON KABUSHIKI KAISHA
18704085 Articles with Photoiniferter Attached to Inorganic Oxide Surface and Polymers Prepared Therefrom Non-Final OA 3M INNOVATIVE PROPERTIES COMPANY
18280770 CLOSED-SYSTEM AUTOMATED SAMPLE SORTING SYSTEM Non-Final OA Sony Group Corporation
17935844 Fabrication-Free Microfluidic Device for Scalable, High-Volume Bacterial Electroporation Non-Final OA Massachusetts Institute of Technology
18301463 DETERGENT COMPOSITIONS CONTAINING ENZYMES Non-Final OA The Procter & Gamble Company
18261267 FREEZING AND JACKETING GAS-PHASE BIOMOLECULES WITH AMORPHOUS ICE FOR ELECTRON MICROSCOPY Non-Final OA Wisconsin Alumni Research Foundation
18576839 INDOOR MICROBIOME MANAGEMENT Non-Final OA SIGNIFY HOLDING B.V.
18027825 OPERATION METHOD AND OPERATION DEVICE FOR LIVING BODY Final Rejection NIKON CORPORATION
18291660 CULTURE METHOD AND CULTURE DEVICE Non-Final OA AISIN CORPORATION
18293618 UNIFORM CELL CULTURE SUBSTRATE FOR FIXED BED BIOREACTOR Non-Final OA CORNING INCORPORATED
17258940 CELL CULTURE SHEET Non-Final OA NIPPON SHOKUBAI CO., LTD.
18515546 CELL CULTURE SURFACES AND CONTAINERS AND METHODS FOR MAKING AND USING THEM Non-Final OA SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION
17439154 METHODS OF OBTAINING LIPIDS FROM A MICROBIAL CELL COMPOSITION BY ENZYME AND PH SHOCK Final Rejection DSM IP Assets B.V.
18547408 MAGNETIC SHEAR BIOREACTOR APPARATUS AND METHODS Non-Final OA THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
17832628 SINGLE CELL WHOLE GENOME AMPLIFICATION VIA MICROPILLAR ARRAYS UNDER FLOW CONDITIONS Final Rejection CORNELL UNIVERSITY
18277591 STERILE CONTAINER FOR CELL CULTURE Final Rejection SUMITOMO BAKELITE CO., LTD.
18633107 ALGINATE HYDROGEL MICROSTRANDS FOR STROMAL CELL ENCAPSULATION, MAINTENANCE AND IMPLANTATION Non-Final OA The Research Foundation for the State University of New York
18508563 Addressable Microfluidics Systems and Methods for In Vivo Applications Final Rejection New Jersey Institute of Technology
18720981 COMPOSITION COMPRISING A LIPASE AND A BOOSTER Non-Final OA Novozymes A/S
18542470 FLOW CELLS Non-Final OA ILLUMINA, INC.
18704555 Micromixer and Method for Concentration Measurement of Unknown Sample Non-Final OA E.F.A. Engineering For All Ltd.
18409552 MICROFLUIDIC DEVICES AND RELATED METHODS Final Rejection ABBOTT DIAGNOSTICS SCARBOROUGH, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Nathan Andrew Bowers's allowance rate?

59.5% of resolved applications examined by Nathan Andrew Bowers were allowed (1,381 resolved cases), compared with 31.6% across Art Unit 1651 over the last five years.

Does an interview help with examiner Nathan Andrew Bowers?

This examiner's interview lift is +31.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Nathan Andrew Bowers take to allow a patent?

Applications allowed by Nathan Andrew Bowers took 1,291 days on average from filing to allowance.

Which art unit does examiner Nathan Andrew Bowers work in?

Nathan Andrew Bowers examines applications in Art Unit 1651 in Tech Center 1700 (Chemistry & Materials).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month